Cargando…
Progression to end-stage renal disease is reduced with eculizumab in patients with atypical haemolytic uraemic syndrome
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472974/ http://dx.doi.org/10.1186/cc14409 |